Applovin Corporation Investing Cash Flow decreased by 101.3% to -$5.25M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 76.8%, from -$22.66M to -$5.25M. Over 3 years (FY 2021 to FY 2024), Investing Cash Flow shows an upward trend with a -55.5% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.00B | -$183.07M | -$8.68M | -$1.06B | -$292.00M | -$42.01M | $0.00 | -$12.98M | -$42.22M | -$15.83M | -$6.80M | -$31.64M | -$68.36M | -$6.40M | -$367.00K | -$22.66M | $401.55M | -$5.25M |
| QoQ Change | — | +81.8% | +95.3% | <-999% | +72.4% | +85.6% | +100.0% | — | -225.4% | +62.5% | +57.0% | -364.9% | -116.1% | +90.6% | +94.3% | <-999% | >999% | -101.3% |
| YoY Change | — | — | — | — | +70.9% | +77.1% | +100.0% | +98.8% | +85.5% | +62.3% | — | -143.8% | -61.9% | +59.6% | +94.6% | +28.4% | +687.4% | +76.8% |